Apr 25 |
Nanobiotix reports FY results
|
Apr 24 |
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
|
Apr 17 |
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
|
Apr 13 |
11 Best Nanotechnology Stocks To Invest In
|
Apr 2 |
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
|
Mar 18 |
Logitech, B. Riley Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
|
Mar 11 |
EQT, Genie Energy And Other Big Stocks Moving Lower On Monday
|
Mar 6 |
Nanobiotix to Present at Upcoming Investor Conferences in March
|
Jan 31 |
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
|
Jan 30 |
Baillie Gifford Bolsters Stake in Nanobiotix SA
|